A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease | MicrobiomeTrials← Back to trialsNCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-04-21Est. Completion: 2028-11-15
Enrollment target: 530 participants Locations- Digestive Health Specialists of the Southeast, Dothan, Alabama, United States
- Clinnova Research, Anaheim, California, United States
- United Gastroenterologists, Los Alamitos, California, United States
- TLC Clinical Research Inc, Los Angeles, California, United States
- Hoag Memorial Hospital, Newport Beach, California, United States
- Peak Gastroenterology Associates, Colorado Springs, Colorado, United States
- Sanchez Clinical Research, Inc, Miami, Florida, United States
- GCP Clinical Research, Tampa, Florida, United States
- Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States
- Westchester Putnam Gastroenterology, Carmel, New York, United States
- New York Gastroenterology Associates, New York, New York, United States
- Charlotte Gastroenterology and Hepatology, PLLC, Charlotte, North Carolina, United States
- Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States
- Digestive Disease Specialists Inc, Oklahoma City, Oklahoma, United States
- Frontier Clinical Research, Uniontown, Pennsylvania, United States
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Palmetto Primary and Specialty Care Physicians, Charleston, Summerville, South Carolina, United StatesSouthern Star Research Institute, LLC, San Antonio, Texas, United StatesGIRI Gastrointestinal Research Institute, Vancouver, British Columbia, CanadaLondon Digestive Disease Institute, London, Ontario, CanadaTaunton Surgical Centre, Oshawa, Ontario, CanadaToronto Immune and Digestive Health Institute Inc, Toronto, Ontario, CanadaClinique IMD, Montreal, Quebec, CanadaThe Sixth Affiliated Hospital Sun Yat sen University, Guangzhou, ChinaSydvestjysk Sygehus, Esbjerg, DenmarkHerlev Hospital, Herlev, DenmarkSahlgrenska Universitetssjukhuset, Mölndal Sjukhus, Mölndal, SwedenErsta sjukhus, Stockholm, SwedenKarolinska Universitetssjukhuset, Stockholm, SwedenBarts Health NHS Trust, Greater London, United KingdomLondon North West University Healthcare NHS Trust, Greater London, United KingdomPhase 4
Recruiting
This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of standard-dose tumor necrosis …
Guangzhou, ChinaEst. completion Dec 31, 2028